IS

Institut Strauss at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Institut Strauss takes part in 4 sessions at ESMO 2026 in Madrid. Its program centres on training and mentoring young oncologists, including fellowship opportunities and learning from professional setbacks. It also discusses new research on melanoma and other skin cancers.

OrganizationESMO 2026 Attendance
IS
Institut Strauss
Strasbourg, France
Cancer centre & hospital
Regional comprehensive cancer centre in Strasbourg, France, and a member of the Unicancer network.
Talk
Fri Oct 23
16:15–17:15
Learning from setbacks: Redefining success in oncology
YO Vesalius Talk · with Oncology Institute of Southern Switzerland (IOSI), Memorial Sloan Kettering Cancer Center
Chair
Sat Oct 24
11:30–12:30
Chair
Sun Oct 25
10:15–11:45
Rapid oral: Melanoma and other skin tumours
with University Medical Center Hamburg-Eppendorf, University College London Hospitals
Melanoma & skin cancers
Abstract
Sun Oct 25
10:30–10:42
Invited Discussant 2073RO, 2074RO and 2075RO
Rapid oral: Melanoma and other skin tumours
Melanoma & skin cancers
Chair
Mon Oct 26
13:00–14:30
ESMO Fellowship Programme: Educational opportunities for young oncologists
with Hospital Clínic de Barcelona, Gustave Roussy
Talk
Mon Oct 26
13:00–13:05
Introduction
ESMO Fellowship Programme: Educational opportunities for young oncologists
Talk
Mon Oct 26
13:45–13:50
Conclusions
ESMO Fellowship Programme: Educational opportunities for young oncologists

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Institut Strauss

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction